Savchuk Nikolay 4
4 · Traws Pharma, Inc. · Filed Mar 10, 2026
Research Summary
AI-generated summary of this filing
Traws Pharma COO Nikolay Savchuk Receives 96,899-Share Award
What Happened
Nikolay Savchuk, Chief Operating Officer of Traws Pharma, was granted a derivative award of 96,899 securities on 2026-03-08. The Form 4 reports the acquisition as an award (code A) with a reported price/value of $0.00. The award is described in the filing footnote as stock options under the Issuer's 2021 Incentive Compensation Plan.
Key Details
- Transaction date: 2026-03-08 (reported on Form 4 filed 2026-03-10).
- Transaction type: Grant/Award of derivative securities (stock options), reporting code A.
- Amount: 96,899 options; filing shows $0.00 per share and total reported value $0.
- Vesting: Footnote states the options will vest 100% on the first anniversary of the grant date.
- Shares owned after transaction: Not specified in the provided filing.
- Timeliness: Filing dated 2026-03-10, two days after the grant date — within the typical Form 4 reporting window.
Context
This was an options award, not a cash purchase or sale. Options give the holder the right to buy shares in the future if exercised; they do not represent immediate ownership or a market sale. Because vesting is delayed (one year cliff), the award signals a future potential equity stake contingent on continued service, but it is not a direct market trade or liquidity event.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-03-08+96,899→ 96,899 totalExercise: $1.60From: 2027-03-08Exp: 2036-03-08→ Common Stock (96,899 underlying)
Footnotes (1)
- [F1]Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.